Huge €62M Series B Boost for Mosa Meat’s Cell-Based Burgers
The Netherlands-based food technology company Mosa Meat has raised €62M in a Series B round…
02/10/2020 - 3 minutes
Trends & News
Medicxi to Shake up the Biotech VC Investment Model with €200M Fund
UK-based investment firm Medicxi aims to attract more investors to the life sciences with a…
01/10/2020 - 4 minutes
How Will AC Immune’s Phase II Fail Impact Alzheimer’s Research?
AC Immune and Genentech’s drug has failed to slow the progression of Alzheimer’s disease in…
29/09/2020 - 6 minutes
Roche Confirms Pharma Appetite for Inflammatory Disease Treatments
Roche’s acquisition of the Irish biotech Inflazome is a vote of confidence for emerging inflammatory…
25/09/2020 - 4 minutes
3D Bioprinting Gains a Foothold in Biomedicine
3D printing has revolutionized manufacturing by reducing costs and giving designers and engineers immense flexibility.…
17/09/2020 - 5 minutes
T-Cell Therapy Firm Wins Massive €93M Series A to Treat Solid Tumors
The Dutch startup Neogene Therapeutics has become the second T-cell therapy developer to raise a…
14/09/2020 - 3 minutes
The Funding Flow Between European and US Life Sciences
Funding is the lifeline of innovative ventures. In an increasingly uncertain environment, looking at the…
14/09/2020 - 11 minutes
The Evolving Arsenal Against Mosquito-Borne Diseases
Genetic engineering is breaking new ground in the control of mosquito-borne diseases. However, a genetic…
10/09/2020 - 8 minutes
Microbiome Therapies Threatened by Covid-19 Restrictions
Providers of microbiome therapies worldwide have been hit by pandemic restrictions on the harvest of…
01/09/2020 - 5 minutes
What Does Unity’s Phase II Fail Mean for European Anti-Aging Research?
A drug developed by the US firm Unity Biotechnology -- designed to slow the aging…
25/08/2020 - 6 minutes
Is Hepatitis D Healthcare Being Overlooked?
Despite the recent EU approval of the first hepatitis D treatment, low public awareness remains…
20/08/2020 - 4 minutes
Women’s Health Gains Traction as Bayer Pays €736M for UK Firm
Bayer’s recent €736M ($875M) acquisition of KaNDy Therapeutics could herald growing investor interest in women’s…
18/08/2020 - 3 minutes
